Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

Exposure to antazoline-naphazoline eye drops during pregnancy and the risk of congenital malformations: a Danish nationwide cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. Seasonal variation in biopsy-proven giant cell arteritis in Eastern Denmark from 1990-2018

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Neonatal vitamin D status and myopia in young adult men

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. Short-term mortality following tramadol poisonings in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Mirtazapine exposure in pregnancy and fetal safety: A nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  4. Drug use in patients with short bowel syndrome and intestinal failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Vis graf over relationer

Purpose: To investigate whether exposure to antazoline-naphazoline eye drops in the first trimester of pregnancy was associated with an increased risk of malformations in humans. Methods: All women giving live birth between 1997 and 2011 in Denmark were included in this nationwide cohort study. All women redeeming at least one prescription of antazoline-naphazoline eye drops during the first 84 days of pregnancy were identified. Logistic regression was used to estimate the odds ratios of malformations among exposed offspring compared to non-exposed offspring. Results: We identified 977 706 births between 1997 and 2011. A total of 3061 women (0.32%) were exposed to antazoline-naphazoline eye drops in the first trimester of pregnancy. The rate of congenital malformations was 3.0% (n = 93) in exposed offspring and 3.5% (n = 33 594) in unexposed offspring. First-trimester exposure to antazoline-naphazoline was not associated with major congenital malformations overall (odds ratio: 0.88, 95% confidence interval: 0.71–1.09) or with any specific major malformation. The number of redeemed prescriptions was unchanged during all trimesters of pregnancy as compared to before and after pregnancy (p < 0.05). Conclusion: Exposure to antazoline-naphazoline eye drops in the first trimester of pregnancy appears not to be associated with increased teratogenic risk.

OriginalsprogEngelsk
TidsskriftActa Ophthalmologica
Vol/bind97
Udgave nummer5
Sider (fra-til)505-509
Antal sider5
ISSN1755-375X
DOI
StatusUdgivet - 2019

ID: 55739493